[Participatory design guide for mental health promotion in prisons]. / Diseño participativo de una Guía para la Promoción de la Salud Mental en el medio penitenciario.

OBJECTIVE: [corrected] The main aim was to describe the issues and the participatory process required to design a Guide to promotemental health in prison through group activities. MATERIAL AND METHOD: We reviewed the bibliography, the mental health policies, the workshops about healthy mental habits, and a video about protection and risk factors. We identified the stakeholders and sought their points of view about the topics included in the Guide. We decided on the contents of the Guide and the incorporation of the health assets model and the perspectives provided by gender and cultural diversity. After the initial design of the modules and sessions, we started a pilot in the Prison of Valencia and the Prison of Zaragoza with women and men from different cultures, incorporating the suggested improvements, unifying contents and the discursive style. RESULTS: The guide is formed by: a preface, introduction, description, modules, sessions and evaluation. It has 6 modules and 19 sessions on: health and motivation; self-esteem; health and emotions; more assets to improve health: relax, positive thinking, keeping calm, communication and problem resolution; progress is possible: resiliency and starring in my own change. Each session consists of: activities (objectives, material, allocated time and development), theoretical material and tabbed sheets for activities. The guide is available in print and online versions. CONCLUSIONS: A guide has been elaborated with involved stakeholders and the opinion of the prison population.

Diseño participativo de una Guía para la Promoción de la Salud Mental en el medio penitenciario / Participatory Design Guide for Mental Health Promotion in Prisons

Objetivos: Describir los contenidos y el proceso participativo de construcción de una guía para promover la salud mental en el medio penitenciario a través de actividades grupales. Material y método: Se realizó una revisión de la literatura, de las políticas de salud mental, de un programa de talleres de hábitos mentales saludables y un vídeo sobre factores de protección y riesgo. Se identificaron a los actores implicados (stakeholders) y se recabó su opinión sobre los temas de la guía. Se decidieron los contenidos de la guía y la incorporación del modelo de activos en salud y las perspectivas de género y diversidad cultural. Tras la elaboración inicial de los módulos y sesiones, se pilotaron en los centros penitenciarios de Valencia y Zaragoza con mujeres y hombres de distintas culturas, incorporando las mejoras sugeridas, unificándose contenidos y el estilo discursivo. Resultados: La guía consta de: prólogo, introducción, descripción, módulos, sesiones y evaluación. Contiene 6 módulos y 19 sesiones sobre: salud y motivación; autoestima; salud y emociones; más activos para ganar salud: relajación, pensar en positivo, mantener la calma, comunicación y resolver problemas; avanzar es posible: resiliencia y ser protagonista de mi cambio. Cada sesión está compuesta por: las dinámicas (objetivos, material, tiempo asignado y desarrollo), material teórico y fichas para las actividades. La guía está disponible en edición impresa y electrónica. Conclusiones: Se ha construido una guía con participación de actores implicados y teniendo en cuenta la opinión de la población penitenciaria (AU)

Objetive: The main aim was to describe the issues and the participatory process required to design a Guide to promote mental health in prison through group activities. Material and Method: We reviewed the bibliography, the mental health policies, the workshops about healthy mental habits, and a video about protection and risk factors. We identified the stakeholders and sought their points of view about the topics included in the Guide. We decided on the contents of the Guide and the incorporation of the health assets model and the perspectives provided by gender and cultural diversity. After the initial design of the modules and sessions, we started a pilot in the Prison of Valencia and the Prison of Zaragoza with women and men from different cultures, incorporating the suggested improvements, unifying contents and the discursive style. Results: The guide is formed by: a preface, introduction, description, modules, sessions and evaluation. It has 6 modules and 19 sessions on: health and motivation; self-esteem; health and emotions; more assets to improve health: relax, positive thinking, keeping calm, communication and problem resolution; progress is possible: resiliency and starring in my own change. Each session consists of: activities (objectives, material, allocated time and development), theoretical material and tabbed sheets for activities. The guide is available in print and online versions. Conclusions: A guide has been elaborated with involved stakeholders and the opinion of the prison population (AU)

[Anticholinesterases in the treatment of Alzheimer's disease]. / Anticolinesterásicos en el tratamiento de la enfermedad de Alzheimer.

INTRODUCTION: Among the numerous pathophysiological theories that attempt to explain the development of Alzheimer's disease (AD) there are two facts that stand out above the rest: on the one hand, the formation of neurofibrillary tangles inside cells and, on the other, the extra-cellular deposition of beta-amyloid protein. These two mechanisms lead to neurodegeneration and the death of cells by means of a process called 'apoptosis' or 'programmed cell death'. In the early stages of this neurodegenerative process it is more pronounced in cholinergic-type brain centres. This led to the formulation of the so-called cholinergic theory of Alzheimer, which provides the rationale behind the use of the drugs that are currently available to treat this disease, namely, acetylcholine esterase (AChE) inhibitors (rivastigmine, donepezil and galanthamine). DEVELOPMENT AND CONCLUSIONS: We review the possible pharmacological approaches that could help to prevent or delay cell death, and which act on the mechanisms involved in the production of neurofibrillary tangles or the deposition of beta-amyloid protein. We also review the main characteristics of cholinergic neurotransmission, which will help us to understand the therapeutic approaches that have been applied in an attempt to enhance deficient cholinergic neurotransmission. One of the most notable of these is the amount of attention recently being paid to the enzyme AChE, which increases the bioavailability of the neurotransmitter in the cholinergic synapses by preventing the hydrolysis of acetylcholine; these are the only drugs currently available for the symptomatic treatment of this disease.